Pharmaceutical

iTeos to shut down following $2bn GSK-partnered TIGIT asset failure

iTeos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.

May 30, 2025 - 06:00
iTeos to shut down following $2bn GSK-partnered TIGIT asset failure
iTeos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.
Read the original article

Tags:

Previous Article

Regeneron to deploy Telesis Bio’s Gibson SOLA at R&D facilities

Next Article

FDA approves Eton’s application for hydrocortisone oral solution

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: The amoxicillin shortage continues to force pediatricians and families to scramble

Opinion: The amoxicillin shortage continues to force pe...

May 9, 2023

Rezvilutamide by Jiangsu Hengrui Medicine for Liver Fai...

Jun 5, 2023

STAT+: South Africa faces court hearing over opaque Covid-19 vaccine contracts

STAT+: South Africa faces court hearing over opaque Cov...

Jul 26, 2023